Photo from wikipedia
This Phase 3 randomized, double‐blind study evaluated the efficacy and safety of plerixafor plus granulocyte‐colony‐stimulating factor for the mobilization of hematopoietic stem cells in Chinese patients with non−Hodgkin's lymphoma. Click to show full abstract
This Phase 3 randomized, double‐blind study evaluated the efficacy and safety of plerixafor plus granulocyte‐colony‐stimulating factor for the mobilization of hematopoietic stem cells in Chinese patients with non−Hodgkin's lymphoma.
Keywords:
stimulating factor;
colony stimulating;
hematopoietic stem;
mobilization hematopoietic;
granulocyte colony;
factor mobilization
Journal Title: Transfusion
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transfusion
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!